Skip to main content

Table 6 Difference in means between treatment and control groups for LDL at final follow-up

From: Screening for thyroid dysfunction and treatment of screen-detected thyroid dysfunction in asymptomatic, community-dwelling adults: a systematic review

Author

Sample size (treatment group vs. control group)

Difference

95% CI

Cabral et al. [57]

32 (14 vs. 18)

− 0.99 mmol/L*

− 2.40 to 0.42

Caraccio et al. [58]

49 (24 vs. 25)

− 0.30 mmol/L*

− 0.83 to 0.23

Duman et al. [60]

39 (20 vs. 19)

0.11 mmol/L*

− 0.89 to 1.11

Iqbal et al. [62]

64 (32 vs. 32)

0.00 mmol/L*

− 0.47 to 0.47

Liu et al. [64]

119 (60 vs. 59)

− 0.12 mmol/L**

− 0.32 to 0.08

Mikhail et al. [66]

120 (60 vs. 60)

− 0.21 mmol/L*

− 0.46 to 0.03

Monzani et al. [68]

45 (23 vs. 22)

− 1.23 mmol/L*

− 2.32 to − 0.13

Nagasaki et al. [69]

95 (48 vs. 47)

− 0.22 mmol/L**

− 0.70 to 0.26

Teixeira et al. [74, 75]

26 (11 vs. 15)

− 0.63 mmol/L*

− 1.90 to 0.64

  1. *Value is the difference in mean scores at final follow-up between treatment and control groups
  2. **Value is the difference in mean variation scores from baseline to follow-up between treatment and control group